B
200780
vs
K
KOSPI 200
Over the past 12 months, BCWorldPharm Co Ltd has underperformed KOSPI 200, delivering a return of -24% compared to KOSPI 200's +153% growth.
Stocks Performance
200780 vs KOSPI 200
Performance Gap
200780 vs KOSPI 200
Performance By Year
200780 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
BCWorldPharm Co Ltd
Glance View
BCWorldPharm is a South Korean pharmaceutical company that develops, manufactures, and sells medicines for everyday medical use. Its product line is centered on prescription drugs and other pharmacy products that doctors, hospitals, and pharmacies use to treat common conditions. It also sells through distributors and, where applicable, supplies products for other companies under manufacturing arrangements. The company makes money by selling finished medicines and related products to healthcare customers and pharmacy channels. In a drug business like this, the main value is not just making pills or injections, but turning regulated formulas into reliable products that can be prescribed, stocked, and dispensed in the market. That means BCWorldPharm sits in the middle of the pharmaceutical supply chain, between drug development and the people who actually use the medicines. What makes its business model different is that it is tied to regulated healthcare demand rather than consumer fashion or broad economic trends. Once a medicine is approved and trusted by doctors and pharmacists, the company can sell it repeatedly through established channels, which makes the business more about product approvals, manufacturing quality, and distribution relationships than about branding alone.
